Daiwa Securities Group Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4
-50.0%
3310.0%0.00%
Q2 2023$8
-27.3%
3310.0%0.00%
Q1 2023$11
+83.3%
3310.0%0.00%
Q4 2022$6
-99.9%
331
+34.6%
0.00%
Q3 2022$7,000
+133.3%
2460.0%0.00%
Q2 2022$3,000
-40.0%
2460.0%0.00%
Q1 2022$5,000
+25.0%
2460.0%0.00%
Q4 2021$4,000
-42.9%
2460.0%0.00%
Q3 2021$7,000
+75.0%
246
+74.5%
0.00%
Q2 2021$4,0000.0%1410.0%0.00%
Q1 2021$4,0000.0%141
+12.8%
0.00%
Q4 2020$4,000
-50.0%
125
-60.6%
0.00%
Q3 2020$8,000
+60.0%
3170.0%0.00%
Q2 2020$5,0000.0%3170.0%0.00%
Q1 2020$5,0000.0%317
+13.2%
0.00%
Q4 2019$5,000
+25.0%
2800.0%0.00%
Q3 2019$4,0000.0%2800.0%0.00%
Q2 2019$4,0000.0%2800.0%0.00%
Q1 2019$4,0000.0%280
+38.6%
0.00%
Q4 2018$4,000
-20.0%
2020.0%0.00%
Q3 2018$5,000
-16.7%
2020.0%0.00%
Q2 2018$6,0000.0%2020.0%0.00%
Q1 2018$6,0002020.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders